Aaron J. Schetter

11.5k total citations · 3 hit papers
60 papers, 8.1k citations indexed

About

Aaron J. Schetter is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Aaron J. Schetter has authored 60 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 33 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Aaron J. Schetter's work include MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (20 papers) and Circular RNAs in diseases (20 papers). Aaron J. Schetter is often cited by papers focused on MicroRNA in disease regulation (29 papers), Cancer-related molecular mechanisms research (20 papers) and Circular RNAs in diseases (20 papers). Aaron J. Schetter collaborates with scholars based in United States, Japan and China. Aaron J. Schetter's co-authors include Curtis C. Harris, Elise D. Bowman, Niels H. H. Heegaard, Carlo M. Croce, Kenneth J. Kemphues, Jane J. Sohn, Suet Yi Leung, Hirokazu Okayama, Siu Tsan Yuen and Nozomu Yanaihara and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Aaron J. Schetter

59 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma

2008 1.3k citations Aaron J. Schetter, Suet Yi Leung et al. JAMA profile →
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

2009 524 citations Aaron J. Schetter, Curtis C. Harris et al. profile →
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer

2013 390 citations Tomer Cooks, Ioannis S. Pateras et al. Cancer Cell profile →

Peers

Aaron J. Schetter

ONCOL

IMMUN

PRM

Gerardo Ferbeyre Canada

Asha S. Multani United States

Rugang Zhang United States

Athena W. Lin United States

Gerhard Fritz Germany

Violeta Serra Spain

Edward V. Prochownik United States

Mats Ljungman United States

William K. Kaufmann United States

Karen Zeller United States

Gerardo Ferbeyre Canada

Aaron J. Schetter

5.5k ×0.9

1.3k ×0.3

2.0k ×1.4

ONCOL

1.1k ×1.6

IMMUN

388 ×0.6

PRM

Citations per year, relative to Aaron J. Schetter Aaron J. Schetter (= 1×) peers Gerardo Ferbeyre

Countries citing papers authored by Aaron J. Schetter

Since Specialization

Citations

This map shows the geographic impact of Aaron J. Schetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron J. Schetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron J. Schetter more than expected).

Fields of papers citing papers by Aaron J. Schetter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron J. Schetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron J. Schetter. The network helps show where Aaron J. Schetter may publish in the future.

Co-authorship network of co-authors of Aaron J. Schetter

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron J. Schetter. A scholar is included among the top collaborators of Aaron J. Schetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron J. Schetter. Aaron J. Schetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jen, Emily Y., Aaron J. Schetter, Donna Przepiorka, et al.. (2018). FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease. Clinical Cancer Research. 25(2). 473–477. 98 indexed citations

Yang, Shouhui, Peijun He, Aaron J. Schetter, et al.. (2016). Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Clinical Cancer Research. 22(24). 5992–6001. 40 indexed citations

Yang, Shouhui, Peijun He, Jian Wang, et al.. (2016). A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Cancer Research. 76(13). 3838–3850. 225 indexed citations

Saito, Motonobu, Kouya Shiraishi, Kenji Matsumoto, et al.. (2014). A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma. Clinical Cancer Research. 20(18). 4784–4793. 31 indexed citations

Okayama, Hirokazu, Aaron J. Schetter, Teruhide Ishigame, et al.. (2014). The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2884–2894. 19 indexed citations

Akagi, Ichiro, Hirokazu Okayama, Aaron J. Schetter, et al.. (2013). Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma. Cancer Research. 73(13). 3821–3832. 38 indexed citations

Cooks, Tomer, Ioannis S. Pateras, Ohad Tarcic, et al.. (2013). Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer. Cancer Cell. 23(5). 634–646. 390 indexed citations breakdown →

Carlsen, Anting Liu, Aaron J. Schetter, Christoffer Tandrup Nielsen, et al.. (2013). Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus. Arthritis & Rheumatism. 65(5). 1324–1334. 187 indexed citations

Du, Xiaoli, Xiaolan Qian, Alex G. Papageorge, et al.. (2012). Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells. Cancer Research. 72(17). 4405–4416. 42 indexed citations

10.

Gaedcke, Jochen, Marian Grade, Jordi Camps, et al.. (2012). The Rectal Cancer microRNAome – microRNA Expression in Rectal Cancer and Matched Normal Mucosa. Clinical Cancer Research. 18(18). 4919–4930. 158 indexed citations

11.

Sohn, Jane J., Aaron J. Schetter, Harris G. Yfantis, et al.. (2012). Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease. PLoS ONE. 7(9). e44156–e44156. 56 indexed citations

12.

Saito, Motonobu, Fumiaki Watanabe, Yoshiko Yamaguchi, et al.. (2012). Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS. Breast Cancer. 21(2). 140–145. 6 indexed citations

13.

Tsuchiya, Naoto, Masashi Izumiya, Hiroko Ogata‐Kawata, et al.. (2011). Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21. Cancer Research. 71(13). 4628–4639. 101 indexed citations

14.

Voortman, Johannes, Akiteru Goto, Jean Mendiboure, et al.. (2010). MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma. Cancer Research. 70(21). 8288–8298. 109 indexed citations

15.

Nguyen, Giang Huong, Aaron J. Schetter, David B. Chou, et al.. (2010). Inflammatory and MicroRNA Gene Expression as Prognostic Classifier of Barrett's-Associated Esophageal Adenocarcinoma. Clinical Cancer Research. 16(23). 5824–5834. 58 indexed citations

16.

Mathé, Ewy A., Giang Huong Nguyen, Elise D. Bowman, et al.. (2009). MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival. Clinical Cancer Research. 15(19). 6192–6200. 319 indexed citations

17.

Schetter, Aaron J., Giang Huong Nguyen, Elise D. Bowman, et al.. (2009). Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma. Clinical Cancer Research. 15(18). 5878–5887. 155 indexed citations

18.

Schetter, Aaron J., Suet Yi Leung, Jane J. Sohn, et al.. (2008). MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma. JAMA. 299(4). 425–36. 1307 indexed citations breakdown →

19.

Gunsalus, Kristin C., Hui Ming Ge, Aaron J. Schetter, et al.. (2005). Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis. Nature. 436(7052). 861–865. 194 indexed citations

20.

Schetter, Aaron J., et al.. (2003). Polarization of the C. elegans zygote proceeds via distinct establishment and maintenance phases. Development. 130(7). 1255–1265. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact